228 related articles for article (PubMed ID: 15804464)
1. Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath.
Shapiro R; Basu A; Tan H; Gray E; Kahn A; Randhawa P; Murase N; Zeevi A; Girnita A; Metes D; Ness R; Bass DC; Demetris AJ; Fung JJ; Marcos A; Starzl TE
J Am Coll Surg; 2005 Apr; 200(4):505-15; quiz A59-61. PubMed ID: 15804464
[TBL] [Abstract][Full Text] [Related]
2. Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy.
McCurry KR; Iacono A; Zeevi A; Yousem S; Girnita A; Husain S; Zaldonis D; Johnson B; Hattler BG; Starzl TE
J Thorac Cardiovasc Surg; 2005 Aug; 130(2):528-37. PubMed ID: 16077423
[TBL] [Abstract][Full Text] [Related]
3. Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning.
Shapiro R; Jordan ML; Basu A; Scantlebury V; Potdar S; Tan HP; Gray EA; Randhawa PS; Murase N; Zeevi A; Demetris AJ; Woodward J; Marcos A; Fung JJ; Starzl TE
Ann Surg; 2003 Oct; 238(4):520-5; discussion 525-7. PubMed ID: 14530723
[TBL] [Abstract][Full Text] [Related]
4. Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation.
Shapiro R; Ellis D; Tan HP; Moritz ML; Basu A; Vats AN; Khan AS; Gray EA; Zeevi A; McFeaters C; James G; Jo Grosso M; Marcos A; Starzl TE
J Pediatr; 2006 Jun; 148(6):813-8. PubMed ID: 16769394
[TBL] [Abstract][Full Text] [Related]
5. Steroid-free tacrolimus monotherapy after pretransplantation thymoglobulin or Campath and laparoscopy in living donor renal transplantation.
Tan HP; Kaczorowski D; Basu A; McCauley J; Marcos A; Donaldson J; Unruh M; Randhawa P; Zeevi A; Shapiro R
Transplant Proc; 2005 Dec; 37(10):4235-40. PubMed ID: 16387087
[TBL] [Abstract][Full Text] [Related]
6. Graft survival and immune regulation of pancreas allograft recipients induced with thymoglobulin, sirolimus, and cyclosporine.
Knight RJ; Kerman RH; Podder H; Katz SM; Van Buren CT; Kahan BD
Transplant Proc; 2005 Mar; 37(2):1280-2. PubMed ID: 15848695
[TBL] [Abstract][Full Text] [Related]
7. A pilot study of immunosuppression minimization after pancreas-kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy.
Knight RJ; Kerman RH; McKissick E; Lawless A; Podder H; Katz S; Van Buren CT; Kahan BD
Transplant Proc; 2005 Oct; 37(8):3538-41. PubMed ID: 16298653
[TBL] [Abstract][Full Text] [Related]
8. Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus.
Marcos A; Eghtesad B; Fung JJ; Fontes P; Patel K; Devera M; Marsh W; Gayowski T; Demetris AJ; Gray EA; Flynn B; Zeevi A; Murase N; Starzl TE
Transplantation; 2004 Oct; 78(7):966-71. PubMed ID: 15480160
[TBL] [Abstract][Full Text] [Related]
9. Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance.
Abu-Elmagd KM; Costa G; Bond GJ; Wu T; Murase N; Zeevi A; Simmons R; Soltys K; Sindhi R; Stein W; Demetris A; Mazariegos G
Transpl Int; 2009 Jan; 22(1):96-109. PubMed ID: 18954362
[TBL] [Abstract][Full Text] [Related]
10. Pancreas transplantation utilizing thymoglobulin, sirolimus, and cyclosporine.
Knight RJ; Kerman RH; Zela S; Podbielski J; Podder H; Van Buren CT; Katz S; Kahan BD
Transplantation; 2006 Apr; 81(8):1101-5. PubMed ID: 16641593
[TBL] [Abstract][Full Text] [Related]
11. Prope tolerance with induction using Campath 1H and low-dose cyclosporin monotherapy in 31 cadaveric renal allograft recipients.
Calne R; Moffatt SD; Friend PJ; Jamieson NV; Bradley JA; Hale G; Firth J; Bradley J; Smith KG; Waldmann H
Nihon Geka Gakkai Zasshi; 2000 Mar; 101(3):301-6. PubMed ID: 10773997
[TBL] [Abstract][Full Text] [Related]
12. Recipient memory-like lymphocytes remain unresponsive to graft antigens after CAMPATH-1H induction with reduced maintenance immunosuppression.
Trzonkowski P; Zilvetti M; Friend P; Wood KJ
Transplantation; 2006 Nov; 82(10):1342-51. PubMed ID: 17130784
[TBL] [Abstract][Full Text] [Related]
13. Long-term Nonhuman Primate Renal Allograft Survival Without Ongoing Immunosuppression in Recipients of Delayed Donor Bone Marrow Transplantation.
Hotta K; Oura T; Dehnadi A; Boskovic S; Matsunami M; Rosales I; Smith RN; Colvin RB; Cosimi AB; Kawai T
Transplantation; 2018 Apr; 102(4):e128-e136. PubMed ID: 29300231
[TBL] [Abstract][Full Text] [Related]
14. Evaluating safety and efficacy of rabbit antithymocyte globulin induction in elderly kidney transplant recipients.
Khanmoradi K; Knorr JP; Feyssa EL; Parsikia A; Jawa P; Dinh DB; Campos S; Zaki RF; Ortiz JA
Exp Clin Transplant; 2013 Jun; 11(3):222-8. PubMed ID: 23432665
[TBL] [Abstract][Full Text] [Related]
15. Tolerogenic immunosuppression for organ transplantation.
Starzl TE; Murase N; Abu-Elmagd K; Gray EA; Shapiro R; Eghtesad B; Corry RJ; Jordan ML; Fontes P; Gayowski T; Bond G; Scantlebury VP; Potdar S; Randhawa P; Wu T; Zeevi A; Nalesnik MA; Woodward J; Marcos A; Trucco M; Demetris AJ; Fung JJ
Lancet; 2003 May; 361(9368):1502-10. PubMed ID: 12737859
[TBL] [Abstract][Full Text] [Related]
16. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
[TBL] [Abstract][Full Text] [Related]
17. Preliminary results of a "prope" tolerogenic regimen with thymoglobulin pretreatment and hepatitis C virus recurrence in liver transplantation.
De Ruvo N; Cucchetti A; Lauro A; Masetti M; Cautero N; Di Benedetto F; Dazzi A; Del Gaudio M; Ravaioli M; Di Francesco F; Molteni G; Ramacciato G; Risaliti A; Pinna AD
Transplantation; 2005 Jul; 80(1):8-12. PubMed ID: 16003226
[TBL] [Abstract][Full Text] [Related]
18. A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients.
Goggins WC; Pascual MA; Powelson JA; Magee C; Tolkoff-Rubin N; Farrell ML; Ko DS; Williams WW; Chandraker A; Delmonico FL; Auchincloss H; Cosimi AB
Transplantation; 2003 Sep; 76(5):798-802. PubMed ID: 14501856
[TBL] [Abstract][Full Text] [Related]
19. Monocyte-mediated acute renal rejection after combined treatment with preoperative Campath-1H (alemtuzumab) and postoperative immunosuppression.
Zhang PL; Malek SK; Prichard JW; Lin F; Yahya TM; Schwartzman MS; Latsha RP; Skaletsky M; Norfolk ER; Brown RE; Hartle JE; Potdar S
Ann Clin Lab Sci; 2004; 34(2):209-13. PubMed ID: 15228236
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression in live-related donor renal transplantation.
Iman A; Rao M; Juneja R; Jacob CK
Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
